Categories: Depression

7/12/2018

Genetic testing to guide antidepressant choices: Big news coverage, but limited evidence

2/23/2018

Newsweek headline overreaches with assertion that “many more” should take antidepressants

1 10/21/2016

Are expensive, potent anti-inflammatory drugs a future option for depression? CNN’s story needed more scrutiny of evidence

7/13/2016

STAT’s story on postpartum depression drug– ‘a paradigm shift’ that needed more scrutiny

6/16/2016

Several errors mar Slate’s story on antidepressant use in kids

2 11/23/2015

Should light therapy be recommended for depression in general — not just in winter?

4 11/4/2015

Textured look at one health system’s relentless suicide prevention efforts

3 10/6/2015

Deep dive into the ethics and evidence underlying genetic testing in depression treatment

5 9/29/2015

Ketamine for depression: NPR coverage leans too heavily on proponents

2 9/17/2015

Nuanced portrait of evidence on prevention benefits of vitamin D

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184319 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532